The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice

<p>Abstract</p> <p>Background</p> <p>Apo2L/TRAIL has considerable promise for cancer therapy based on the fact that this member of the tumor necrosis factor family induces apoptosis in the majority of malignant cells, while normal cells are more resistant. Furthermore,...

Full description

Bibliographic Details
Main Authors:	Oktay Dilek, Gibbs John F, Penetrante Remedios B, Pitoniak Rose, Hylander Bonnie L, Cheng Jinrong, Repasky Elizabeth A
Format:	Article
Language:	English
Published:	BMC 2005-05-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/3/1/22

Similar Items

Outcome of Xenografted Fetal Porcine Pancreatic Tissue is Superior in Inbred Scid (C.B-17/Icr-scid/scid) Compared to Outbred Nude (CD-1-nu/nu) Mice
by: Bernard E. Tuch Ph.D., et al.
Published: (1999-05-01)

Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
by: Ferrone Soldano, et al.
Published: (2007-06-01)

Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
by: Jon-Vidar Gaustad, et al.
Published: (2019-08-01)

Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.
by: Anna B Wennerström, et al.
Published: (2014-01-01)

Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients
by: Alice Usai, et al.
Published: (2021-08-01)

Temperature as a modulator of the gut microbiome: what are the implications and opportunities for thermal medicine?
by: Bonnie L. Hylander, et al.
Published: (2019-11-01)

Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis.
by: Kenji Unno, et al.
Published: (2014-01-01)

Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
by: Sandra Roche, et al.
Published: (2020-01-01)

Fine Needle Ethanol Injection Therapy for Human Pancreatic Adenocarcinoma Subcutaneously Xenografted in Nude Mice
by: Pierre C Gagnon, et al.
Published: (1993-01-01)

Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts
by: Martyna Krzykawska-Serda, et al.
Published: (2018-06-01)

Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu
by: Sadaf Aghevlian, et al.
Published: (2020-11-01)

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
by: Inoue Takeshi, et al.
Published: (2013-01-01)

E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model.
by: Daniel Wicklein, et al.
Published: (2013-01-01)

Genetics of SCID
by: Cossu Fausto
Published: (2010-11-01)

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
by: Voelkel-Johnson Christina, et al.
Published: (2005-01-01)

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
by: Rémy Nicolle, et al.
Published: (2017-11-01)

A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model.
by: Martin F Strand, et al.
Published: (2011-01-01)

Hematological and biochemical profile of BALB/c nude and C57BL/6 SCID female mice after ovarian xenograft
by: DENILSA P. FERNANDES, et al.
Published: (2018-10-01)

Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
by: Bhadri Vivek A, et al.
Published: (2011-11-01)

Antibody directed against human YKL-40 increases tumor volume in a human melanoma xenograft model in scid mice.
by: Johannes Salamon, et al.
Published: (2014-01-01)

Validation of the NetSCID: an automated web-based adaptive version of the SCID
by: Benjamin B. Brodey, et al.
Published: (2016-04-01)

Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
by: Robert J Torphy, et al.
Published: (2014-01-01)

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
by: Ilaria Pergolini, et al.
Published: (2017-01-01)

DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts
by: Catherine S. Wegner, et al.
Published: (2018-07-01)

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
by: Chen Qinghe, et al.
Published: (2008-01-01)

Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
by: Marco Righi, et al.
Published: (2013-01-01)

Correction: D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies.
by: Marco Righi, et al.
Published: (2013-01-01)

A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma
by: Zhenyang Liu, et al.
Published: (2020-06-01)

Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment
by: Matthew C. Hernandez, et al.
Published: (2019-01-01)

Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
by: Dustin M Walters, et al.
Published: (2013-01-01)

AXL Mediates TRAIL Resistance in Esophageal Adenocarcinoma
by: Jun Hong, et al.
Published: (2013-03-01)

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.
by: Paola Secchiero, et al.
Published: (2010-01-01)

(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies.
by: Marco Righi, et al.
Published: (2013-01-01)

Comparison between NOD/SCID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer
by: Wu J, et al.
Published: (2018-12-01)

Study on the molecular mechanism of induced-apoptosis by a methoxy derivative of resveratrol in human colorectal carcinoma COLO 205 cells and xenografts in SCID mice
by: Jia-Hui Gao, et al.
Published: (2006)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
by: Matthew Loft, et al.
Published: (2019-07-01)

Implementation of SCID Screening in Denmark
by: Marie Bækvad-Hansen, et al.
Published: (2021-08-01)

A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts
by: Meike Beer, et al.
Published: (2017-04-01)

Analysis of Hemopoietic Malignancy in IgHm-TLX1TgPrkdcScid/Scid Mice
by: Krutikov, Konstantin
Published: (2014)

In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts.
by: Robert J Wolf, et al.
Published: (2013-01-01)